Biotech companies, investors pour billions into mRNA vaccines as research ramps up in cancer and non-communicable diseases

After the stunning success of mRNA vaccines during the COVID-19 pandemic, researchers and biotech companies are racing to prove the utility of the technology in an array of non-communicable diseases—including cancer, cystic fibrosis, and sickle cell disease.